Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 09-2015 | 06-2015 | 12-2014 | |
| Operating Expenses | 0 | 4,021 | 3,083 | 0 |
| Operating Income | N/A | -4,021 | -3,083 | N/A |
| Other Income | 0 | 572 | -136 | 0 |
| Pre-tax Income | 0 | -3,449 | -3,219 | 0 |
| Net Income Continuous | N/A | -3,449 | -3,219 | N/A |
| Net Income | $N/A | $-3,449 | $-3,219 | $N/A |
| EPS Basic Total Ops | N/A | -12.79 | -13.78 | N/A |
| EPS Basic Continuous Ops | N/A | -12.68 | -13.78 | N/A |
| EPS Diluted Total Ops | N/A | -12.79 | -13.78 | N/A |
| EPS Diluted Continuous Ops | N/A | -12.68 | -13.78 | N/A |
| EBITDA(a) | $N/A | $-3,972 | $-3,083 | $N/A |